WHO ARE WE?

Professional shareholder of value-creating companies for 20 years.

Founded in 1999, the Turenne Group supports companies, start-ups, SMEs and intermediate-sized enterprises, providing equity financing at each stage of their development across all of France.

1.5 BILLIONS € UNDER MANAGEMENT

80 Professionals

65 Investors

240 Companies in portfolio

30 M€ INVESTMENT TICKET

Our Sector strategies

Presence in French regions

The Turenne Group in 1 minute

Latest news

Turenne Groupe launches the Next Health Capital fund and boosts its teams dedicated to healthcare innovation
Press release

Turenne Groupe launches the Next Health Capital fund and boosts its teams dedicated to healthcare innovation
Domain Therapeutics raises $42m Series A financing
Press articles

Domain Therapeutics raises $42m Series A financing
GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector
New

GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector
StromaCare has raised €1,500,000 for the development of a new oncology therapy based on the immuno-modulation of the tumor stroma using a monoclonal antibody.
New

StromaCare has raised €1,500,000 for the development of a new oncology therapy based on the immuno-modulation of the tumor stroma using a [...]
Phodé, a laboratory specialising in natural sensory solutions, reorganised its share capital with the entry of Turenne Santé as a minority shareholder
Press release

Phodé, a laboratory specialising in natural sensory solutions, reorganised its share capital with the entry of Turenne Santé as a minority [...]
Turenne Santé, supported by BNP Paribas Développement, becomes a minority shareholder in the capital of H.A.C.Pharma to support the company in its growth and strengthen the product portfolio
New

Turenne Santé, supported by BNP Paribas Développement, becomes a minority shareholder in the capital of H.A.C.Pharma to support the company in its [...]
Innovacom acquires a stake in Primo1D, world leader in smart electronic thread
New

Innovacom acquires a stake in Primo1D, world leader in smart electronic thread
AI Verse raises 2.5 million euros from Innovacom and Bpifrance
New

AI Verse raises 2.5 million euros from Innovacom and Bpifrance
Innovacom supports GreenWaves Technologies new funding round
New

Innovacom supports GreenWaves Technologies new funding round
Innovacom acquires a stake in SustainCERT
New

Innovacom acquires a stake in SustainCERT
Amolyt Pharma Announces $80 MillionSeries B Financing led by Sectoral Asset Management and Andera Partners
Press release

Amolyt Pharma Announces $80 MillionSeries B Financing led by Sectoral Asset Management and Andera Partners
HalioDx and Veracyte set proposed acquisition terms
New

HalioDx and Veracyte set proposed acquisition terms
All news